Kairos Pharma, LTD. (KAPA) › Cash & EquivalentsKairos Pharma, LTD. (KAPA) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2024: $1.27M2025: $4.49M$4.49M2024Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$4.49M+253.1%2024$1.27M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share